Atalanta Therapeutics: Funding, Investors & Team (Oct 2026)
Atalanta Therapeutics is an innovative biotechnology company that is leading the way in developing new therapies for neurodegenerative diseases through the use of its unique RNA interference technology.
Atalanta Therapeutics has raised $207M across 2 funding rounds on record, the most recent a Series B of $97.0M announced in Jan 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Atalanta Therapeutics Company Profile and Key Stats
Latest funding round on record: Jan 2025.
Atalanta Therapeutics Funding Rounds
Atalanta Therapeutics raised $110M in a Series A announced in Jan 2021.
4 years later, a Series B of $97.0M was announced in Jan 2025.
Atalanta Therapeutics Founders and Leadership Team
No contact details are on record for this team yet.
Atalanta Therapeutics Funding Compared to Other Biotechnology Startups
Atalanta Therapeutics' latest round of $97.0M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Atalanta Therapeutics in Biotechnology and Boston
Companies Similar to Atalanta Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Atalanta Therapeutics Funding FAQs
What does Atalanta Therapeutics do?
Atalanta Therapeutics is an innovative biotechnology company that is leading the way in developing new therapies for neurodegenerative diseases through the use of its unique RNA interference technology.
How much funding has Atalanta Therapeutics raised?
Atalanta Therapeutics has raised $207M across 2 rounds on record. The most recent is a Series B of $97.0M announced in Jan 2025.
When did Atalanta Therapeutics last raise funding?
Atalanta Therapeutics' most recent funding round on record is a Series B of $97.0M, announced in Jan 2025.
Who founded Atalanta Therapeutics?
FundedIQ lists Neil Aronin (Founder) at Atalanta Therapeutics.
Who is the CEO of Atalanta Therapeutics?
Alicia Secor is listed as CEO at Atalanta Therapeutics.
Where is Atalanta Therapeutics headquartered?
Atalanta Therapeutics is based in Boston, Massachusetts, United States.
How many employees does Atalanta Therapeutics have?
Atalanta Therapeutics is in the 51-100 employee band.
How does Atalanta Therapeutics' funding compare to other Biotechnology startups?
Atalanta Therapeutics' latest round of $97.0M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Atalanta Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Atalanta Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.